Identification and evaluation of a lipid-lowering small compound in preclinical models and in a Phase I trial.
Wang J, Zhao J, Yan C, Xi C, Wu C, Zhao J, Li F, Ding Y, Zhang R, Qi S, Li X, Liu C, Hou W, Chen H, Wang Y, Wu D, Chen K, Jiang H, Huang H, Liu H.
Wang J, et al. Among authors: yan c.
Cell Metab. 2022 May 3;34(5):667-680.e6. doi: 10.1016/j.cmet.2022.03.006. Epub 2022 Apr 14.
Cell Metab. 2022.
PMID: 35427476
Free article.
Clinical Trial.